secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2025-08-29T23:59:59+00:00
Accession:  0001826667-25-000129
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

TriSalus Life Sciences raises CFO base salary to $550K, grants performance-based stock options
--------------------------------------------------------------------------------

- CFO David Patience's annual base salary increased from $450K to $550K, effective immediately.
- Compensation Committee approved stock options for 249,899 shares at $5.11 per share.
- Options vest upon company achieving ≥$75M revenue in any 12 consecutive months by Dec 31, 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000182666725000129/0001826667-25-000129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000182666725000129/tlsi-20250825.htm
  HTML page:      https://secwatch.observer/filing/0001826667-25-000129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer